Dec 12 (Reuters) - Alzheimer's trials testing Novo Nordisk’s blockbuster GLP-1 drug semaglutide, despite their failure, ...

In a new study published in Neurochemistry International, scientists from Kindai University in Japan discovered that a common ...

Japan is grappling with a fast-growing dementia crisis as thousands of older people wander from their homes each year. Police data shows that more than 18,000 dementia patients went missing in 2023, ...

A new study finds that taking arginine orally may lower amyloid buildup and neuroinflammation, suggesting a safe, low-cost ...

In 2023, the United States represented the largest market for Alzheimer's disease, accounting for approximately 54% of the total market size across the 7MM, compared to other major markets such as the ...

A conceptual illustration depicting key cognitive symptoms of Alzheimer’s disease—memory impairment, disorientation, and executive dysfunction. These symptoms represent the primary manifestations of ...

The Rutgers Krieger Klein Alzheimer's Research Center has received a $1.5 million philanthropic gift from the Norman and Mary ...

"I just know that my brain's not right," said Carrie Richardson, 44. "And so, I hate it. I just want it to be normal." At 41, Carrie developed early-onset Alzheimer's disease. The condition is caused ...